"I would be surprised to be told that the assays have not been done and assessed by HQ. Also, I would not be surprised to learn that they are not price-sensitive ('material' etc)"
Assays would not have been done mate. If they were, it would be classed as price sensitive and released immediately. You can see from their history of announcements - every single hole that returned results has been announced as price sensitive, because it is material. Every single update on their drilling programs has been price sensitive, because this is also material.
It is simply, it has not been done, which brings me back to exactly how much drilling have they completed in 23.5 weeks. They had no problem releasing CC holes separately. They had no problem updating the market on the analysis of the cores prior to assays.
Makes me believe BT has returned nothing. Which will make it extremely hard to raise funds at a reasonable price and without bending the current investors over with massive CR discounts. No choice but to continue waiting and see, just speculation for now, formed however from the company's history of communication (which you can project forward and note failure or success before it happens).
I agree Steam Engine should be priority, which confirms my statement that on the surface, management are in over their heads and don't have direction.
~10 months for the process option study at SE... where are the reports? We were told the study was nearing completion in January, and to be expected late Feb. It's now April and nothing. Not even an update.
Like I said, something stinks. IMO they're going to try and make something of nothing, in an effort to inflate the share price - or maybe just shameless and will cap raise at huge discounts to friends. In too deep and have to see it out, so can only hope for the best, but preparing for the worst.
- Forums
- ASX - By Stock
- SPQ
- Ann: Phase 2 Drilling Program commences at Bottletree
Ann: Phase 2 Drilling Program commences at Bottletree, page-166
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPQ (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.1¢ |
Change
-0.001(8.33%) |
Mkt cap ! $24.01M |
Open | High | Low | Value | Volume |
1.2¢ | 1.2¢ | 1.1¢ | $11.58K | 987.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 2145720 | 1.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.1¢ | 240296 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 117546 | 0.011 |
5 | 2145720 | 0.010 |
6 | 3235000 | 0.009 |
7 | 1209464 | 0.008 |
8 | 1774928 | 0.007 |
Price($) | Vol. | No. |
---|---|---|
0.012 | 2337063 | 4 |
0.013 | 1400000 | 3 |
0.014 | 1066915 | 2 |
0.015 | 375000 | 1 |
0.016 | 82500 | 2 |
Last trade - 13.55pm 15/07/2024 (20 minute delay) ? |
Featured News
SPQ (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online